NJ State Employees Deferred Compensation Plan - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$835,000
-37.2%
100,0000.0%0.13%
-33.9%
Q2 2023$1,330,000
+14.9%
100,0000.0%0.19%
+7.3%
Q1 2023$1,158,000
+41.6%
100,0000.0%0.18%
+35.6%
Q4 2022$818,000
+40.8%
100,0000.0%0.13%
+32.0%
Q3 2022$581,000
+31.4%
100,0000.0%0.10%
+38.9%
Q2 2022$442,000
-51.4%
100,0000.0%0.07%
-41.5%
Q1 2022$910,000
-55.5%
100,0000.0%0.12%
-52.1%
Q4 2021$2,046,000
-19.9%
100,0000.0%0.26%
-25.9%
Q3 2021$2,555,000
-26.9%
100,0000.0%0.35%
-25.4%
Q2 2021$3,497,000
+5.0%
100,0000.0%0.46%
-1.9%
Q1 2021$3,331,000
+28.4%
100,0000.0%0.47%
+18.5%
Q4 2020$2,594,000
+162.8%
100,0000.0%0.40%
+126.0%
Q3 2020$987,000
+186.1%
100,0000.0%0.18%
+172.3%
Q2 2020$345,000
+12.7%
100,0000.0%0.06%
-7.1%
Q1 2020$306,000
-40.5%
100,0000.0%0.07%
-19.5%
Q4 2019$514,000
-0.4%
100,0000.0%0.09%
-7.4%
Q3 2019$516,000
-14.7%
100,0000.0%0.09%
-13.8%
Q2 2019$605,000
+4.7%
100,000
+25.0%
0.11%
+3.8%
Q1 2019$578,000
+56.2%
80,000
+60.0%
0.10%
+36.4%
Q4 2018$370,00050,0000.08%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q4 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,660,000$24,206,00011.49%
Data Collective II GP, LLC 164,249$1,495,0005.44%
Decheng Capital Management III (Cayman), LLC 1,463,872$13,321,0004.08%
SB Management Ltd 1,886,107$17,164,0003.33%
Casdin Capital, LLC 7,990,652$72,715,0003.26%
ORACLE INVESTMENT MANAGEMENT INC 1,225,395$11,151,0002.20%
Jackson Square Partners, LLC 22,542,589$205,137,0002.04%
BOURNE LENT ASSET MANAGEMENT INC 556,865$5,067,0001.59%
ARK Investment Management 27,259,521$248,062,0001.04%
Nikko Asset Management Americas, Inc. 14,021,205$127,873,0000.94%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders